Topical Rapamycin — Vitiligo’s Next Big Hope? (Ep. 54)
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Topical Rapamycin — Vitiligo’s Next Big Hope? (Ep. 54)
-
Narrated by:
-
By:
About this listen
From Easter Island soil to modern skin science — meet rapamycin, the molecule that might just change vitiligo care.
Once known mainly as an anti-rejection drug for organ transplants, rapamycin is now being tested as a topical treatment that could both calm the immune attack and help pigment return. Early studies look promising: minimal side effects, slow but steady repigmentation, and surprisingly good tolerance.
In this episode, we explore:
- How rapamycin rewires the skin’s immune balance
- Why it’s called both a suppressor and a rejuvenator
- What Phase II trials are revealing so far
- And whether this “longevity drug” might also restore color to the skin
It’s too early to call it a breakthrough — but this little molecule from a far-off island might just be the next quiet revolution in vitiligo therapy.
Full story: Topical Rapamycin: Could This Be Vitiligo’s Next Big Breakthrough?
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.